Global Type 1 Diabetes Market 2014-2018

2014-05-30
Price :
Published : May-2014
No. of Pages : 85

Type 1 diabetes is an autoimmune disorder characterized by high blood glucose levels. In this condition, the immune system is activated against self-insulin producing cells. This, in turn, hampers the body’s ability to produce insulin and disrupts blood glucose homeostasis. Type 1 diabetes T1D differs from the more common form of diabetes mellitus, Type 2 diabetes, as people with Type 2 diabetes do produce insulin. T1D accounts for only 5-15 percent of the total diabetic cases and is usually reported in children and adolescents. T1D was formerly known as juvenile diabetes. T1D management relies on providing symptomatic relief and improving quality of life.

TechNavio’s analysts forecast the Global Type 1 Diabetes Market will grow at a CAGR of 6.9 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Type 1 Diabetes Market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of various type 1 diabetes management drugs, which includes insulin-based replacement products and amylin analogues.

TechNavio’s report, the Global Type 1 Diabetes Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Type 1 Diabetes market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Astrazeneca plc
  • Eli Lilly and Co.
  • Novo Nordisk A/S
  • Sanofi-Aventis US LLC

Other Prominent Vendors

  • Biodel Inc.
  • Diamyd Medical AB
  • DiaVacs Inc.
  • Generex Biotechnology Corp.
  • Lexicon Pharmaceuticals Inc.
  • Macrogenics Inc.
  • MannKind Corp.
  • Osiris Therapeutics Inc.
  • Tolerion Inc.
  • XOMA Corp.

Key Market Driver

  • Increasing Global Type 1 Diabetic Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • Side Effects of Current Therapies.
  • For a full, detailed list, view our report.

Key Market Trend

  • Focus on Emerging Markets.
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

Digital Landscape: Breast Cancer

Digital Landscape: Breast Cancer Summary The "Digital Landscape: Breast Cancer", report analyzes digital activities undertaken by pharma in support of therapies for breast cancer. Key Highlights - US Patients: Strong digital support for US breast cancer patients in the US, particularly from Pfizer, Novartis and AstraZeneca. Most recent branded activity seen from Lilly and Novartis in the CDK4/6 inhibitor space. Most unbranded and social media activity focuses on supporting patients with metastatic breast cancer. Few breast cancer-specific mobile apps detected in the US. - US HCPs: There is little support for HCPs in the breast cancer space beyond branded. AstraZeneca, Genentech, Novartis and Pfizer offer examples of strong branded resources. The pharma-sponsored unbranded and ......
$6000

Digital Landscape: Inflammatory Bowel Disease

Digital Landscape: Inflammatory Bowel Disease Summary The Digital Landscape Inflammatory Bowel Disease report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn's disease and ulcerative colitis (UC). Key Highlights - US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen was the most active competitor in the branded and social media spaces in 2017. Branded activity also seen from pipeline and biosimilar competitors. No IBD-specific mobile apps detected from pharma. Opportunity exists for a well-integrated unbranded campaign to support patients, linked to social media and a mobile app. - US HCPs: Good support av......
$6000

PharmSource – Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook – 2018 Edition

PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook - 2018 Edition Summary The motivation for pharma companies outsourcing their manufacturing is often to do with lacking expertise, equipment, or cost reduction (especially for small to mid-sized CMOs) in development of their product's API or dose. For clinical dose manufacturing, there is a high risk associated with the pipeline drug product and as such using a CMO for this mitigates risk for pharma companies that may otherwise have to invest in equipment and facilities. This report, the 2018 version in this annual series, characterizes the contract dose manufacturing industry along a number of quantitative dimensions, including number and type of participants, market size, m......
$4995

Healthcare Industry Business Outlook and Procurement Report July 2018 – December 2018

Healthcare Industry Business Outlook and Procurement Report July 2018 - December 2018 Summary GlobalData's "Healthcare Industry Business Outlook and Procurement Report July 2018 - December 2018", examines executives' opinions on the business outlook and procurement activities over July-December 2018. Organizations can know about key business priorities, changes in capital expenditure, global revenue contributors, and key information about the organizations' digital transformation strategies along with investment in emerging technologies. Additionally, it provides information categorized by region and company types. The highest percentages of healthcare industry executives identify expansion in the current market and new product development as the foremost priorities of healthcare ......
$1950

Kidney Transplant Rejection Global Clinical Trials Review, H2, 2018

Kidney Transplant Rejection Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Kidney Transplant Rejection Global Clinical Trials Review, H2, 2018" provides an overview of Kidney Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Kidney Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary......
$2500

House Dust Mite Allergy Global Clinical Trials Review, H2, 2018

House Dust Mite Allergy Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "House Dust Mite Allergy Global Clinical Trials Review, H2, 2018" provides an overview of House Dust Mite Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on House Dust Mite Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Phar......
$2500

Amyotrophic Lateral Sclerosis: Epidemiology Forecast to 2027

Amyotrophic Lateral Sclerosis: Epidemiology Forecast to 2027 Summary ALS is a rare but fatal progressive neurodegenerative disease that affects the nerve cells in the brain and the spinal cord (Doi et al., 2014). ALS is often referred to as "Lou Gehrig's Disease" after the famous baseball player. ALS severely impacts physical functioning, and initially presents with muscle twitching, weakness in an arm or leg, or sometimes with slurring of speech. Eventually, people with ALS lose their ability to control the muscles needed to move, speak, eat, and breathe, which ultimately leads to death. GlobalData epidemiologists used age- and sex-specific diagnosed prevalence rates to forecast the diagnosed prevalent cases, and used the diagnosis rate and diagnosed prevalence to calculate total......
$3995

Hematology Analyzers – Medical Devices Pipeline Assessment, 2018

Hematology Analyzers - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Hematology Analyzers - Medical Devices Pipeline Assessment, 2018" provides an overview of Hematology Analyzers currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Analyzers pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by......
$2500

Thyroid Function Tests – Medical Devices Pipeline Assessment, 2018

Thyroid Function Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Thyroid Function Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Thyroid Function Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Thyroid Function Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary res......
$4000

Hematology Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2018

Hematology Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Hematology Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018" provides an overview of Hematology Rapid Tests & Point of Care (POC) currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Rapid Tests & Point of Care (POC) pipeline products. This ......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy